Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

REVEALED: Embecta - The Real Truth

Embecta Faces U.S. Reset as CEO Bets on GLP-1, Owen Mumford Diversification

Embecta (NASDAQ:EMBC) President and CEO Devdatt Kurdikar said the company’s recent U.S. business reset reflected a combination of customer-specific share loss, softer market trends and inventory-related factors, while emphasizing that the diabetes device maker is continuing a broader diversification

MarketBeat · May 16

Is Embecta a Medical Device Company Worth Adding to Your Portfolio?

Driven by an increasingly prominent aging population and technological breakthroughs, the prospects of the medical devices industry are surging. So, should investors looking to capitalize on the industry’s growth prospects add Embecta (EMBC) to their portfolio? Read more….

StockNews.com · Jan 20, 2025

Polyphotonix strikes deal with diabetes care firm for innovative sleep mask

The link-up has been described as a 'turning point' for the County Durham firm and a step towards it international expansion

Birmingham Post · Apr 3, 2023

From analysis to the latest developments in health,
read the most diverse news in one place.

Why This Analyst Feels It's Time To Short Embecta

Despite being a market leader in insulin pen needles and syringes, Embecta Corp (NASDAQ: EMBC) may face challenges ahead, since the markets are already mature and the company has not diversified, according to BofA Securities.

Benzinga · Jun 21, 2022

Why Embecta Shares Are Falling Today

Becton Dickinson and Co's (NYSE:BDX) pure-play diabetes spin-off Embecta Corp (NASDAQ:EMBC) has reported Q2 sales of $274.5 million, down 3.4% on a reported basis, down 1.3% on a constant currency basis. Of the decrease, $6.0 million was attributable to unfavorable effects from foreign currency translation. Volume unfavorably impacted revenues by approximately $3.7 million, primarily…

Benzinga · May 13, 2022

Coverage From

Organisations

Medical Devices Equipment

13 stories

EMBC

11 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

diabetes

2,891 stories

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.